1. Ambrogi, V., Bloch, K., Daturi, S., Griggi, P., Logemann, W., Mandeli, V., Parenti, M.A., Babini, T., Usardi, M.M., Tommasini, R.: Pharmacological study on a new antidiabetic: N-{4-[?-(5-methyl-pyrazine-2-carboxamido)-ethyl]-benzene-sulfonyl}-N?-cyclohexyl urea or K 4024. Arzneimittel-Forsch.21, 208?215 (1971)
2. Pedrazzi, F., Pisani Ceretti, A., Losi, S., Bommartini, F., Artini, D., Emanueli, A.: Evaluation in hospitalized subjects of a new hypoglycemic sulfonylurea, glydiazinamide. Arzneimittel-Forsch.21, 220?225 (1971)
3. Ambrogi, V., Artini, D., Fucella, L.M., Goldaniga, G., Orsini, G., Ronchi, R., Tamassia, V., Valzelli, G., Angelucci, R.: Farmacocinetica e metabolismo in animali da esperimento e nell'uomo della N-{4-[?-(5-metilpirazina-2-eorbossiamido)-etil]-benzensulfonil}-N? cicloesil-urea (K 4024). Boll. chim. farm.111, 251?264 (1972)
4. Stowers, J.M., Constable, L.W., Hunter, B.B.: A clinical and pharmacological comparison of chlorpropamide and other sulfonylureas. Ann. N. Y. Acad. Sci.74, 689?695 (1959)
5. Ueda, H., Sakurai, T., Ota, M., Nakajima, A., Kamii, K., Maezawa, H.: Disappearance rate of tolbutamide in normal subjects and in diabetes mellitus, liver cirrhosis and renal disease. Diabetes12, 414?419 (1963)